Exact Mass: 371.13035560000003
Exact Mass Matches: 371.13035560000003
Found 500 metabolites which its exact mass value is equals to given mass value 371.13035560000003,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Trazodone
A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309) CONFIDENCE standard compound; INTERNAL_ID 712; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7040; ORIGINAL_PRECURSOR_SCAN_NO 7038 CONFIDENCE standard compound; INTERNAL_ID 712; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6960; ORIGINAL_PRECURSOR_SCAN_NO 6956 CONFIDENCE standard compound; INTERNAL_ID 712; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7037; ORIGINAL_PRECURSOR_SCAN_NO 7034 CONFIDENCE standard compound; INTERNAL_ID 712; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6996; ORIGINAL_PRECURSOR_SCAN_NO 6993 D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants CONFIDENCE standard compound; INTERNAL_ID 2271 D049990 - Membrane Transport Modulators Trazodone (AF-1161 free base) is a serotonin receptor antagonist and reuptake inhibitor. Trazodone can be used for the research of major depressive disorder. Trazodone also has potential for sleep disorder research[1].
1,2,3,10-Tetramethoxy-7-(methylamino)-6,7-dihydro-5H-benzo[a]heptalen-9-one
ATC code: L01CC01 Colcemid (Demecolcine) is a potent mitotic inhibitor with an IC50 value of 2.4 μM for inhibition of tubulin polymerization. Colcemid (Demecolcine) can interact with tubulin dimers to induce anti-mitotic action and inhibit microtubule growth. Colcemid (Demecolcine) can be used for inflammatory disorders and cancer research[1][2]. Colcemid (Demecolcine) is a potent mitotic inhibitor with an IC50 value of 2.4 μM for inhibition of tubulin polymerization. Colcemid (Demecolcine) can interact with tubulin dimers to induce anti-mitotic action and inhibit microtubule growth. Colcemid (Demecolcine) can be used for inflammatory disorders and cancer research[1][2].
Nedocromil
Nedocromil is only found in individuals that have used or taken this drug. It is a pyranoquinolone derivative that inhibits activation of inflammatory cells which are associated with asthma, including eosinophils, neutrophils, macrophages, mast cells, monocytes, and platelets. [PubChem]Nedocromil has been shown to inhibit the in vitro activation of, and mediator release from, a variety of inflammatory cell types associated with asthma, including eosinophils, neutrophils, macrophages, mast cells, monocytes, and platelets. Nedocromil inhibits activation and release of inflammatory mediators such as histamine, prostaglandin D2 and leukotrienes c4 from different types of cells in the lumen and mucosa of the bronchial tree. These mediators are derived from arachidonic acid metabolism through the lipoxygenase and cyclo-oxygenase pathways. The mechanism of action of nedocromil may be due partly to inhibition of axon reflexes and release of sensory neuropeptides, such as substance P, neurokinin A, and calcitonin-geneñrelated peptides. The result is inhibition of bradykinin-induced bronchoconstriction. Nedocromil does not posess any bronchodilator, antihistamine, or corticosteroid activity. R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BC - Antiallergic agents, excl. corticosteroids R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AC - Antiallergic agents, excl. corticosteroids S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D000893 - Anti-Inflammatory Agents > D000082142 - Mast Cell Stabilizers D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents D018926 - Anti-Allergic Agents D007155 - Immunologic Factors Nedocromil suppresses the action or formation of multiple mediators, including histamine, leukotriene C4 (LTC4), and prostaglandin D2 (PGD2).
Isoandrocymbine
Isoandrocymbine is an isoquinoline alkaloid. Isoandrocymbine has been reported in Colchicum autumnale
Berberine chloride
C20H18NO4. Cl (371.09242980000005)
Berberine chloride is an alkaloid that acts as an antibiotic. Berberine chloride induces reactive oxygen species (ROS) generation and inhibits DNA topoisomerase. Antineoplastic properties[1]. Berberine chloride is an alkaloid that acts as an antibiotic. Berberine chloride induces reactive oxygen species (ROS) generation and inhibits DNA topoisomerase. Antineoplastic properties[1].
Ampicillin sodium
C16H18N3O4S. Na (371.09156680000007)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic Same as: D02119
isradipine
C19H21N3O5 (371.14811360000004)
C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Isradipine
C19H21N3O5 (371.14811360000004)
Isradipine belongs to the dihydropyridine (DHP) class of calcium channel blockers (CCBs), the most widely used class of CCBs. It is structurally related to felodipine, nifedipine, and nimodipine and is the most potent calcium-channel blocking agent of the DHP class. Isradipine binds to calcium channels with high affinity and specificity and inhibits calcium flux into cardiac and arterial smooth muscle cells. It exhibits greater selectivity towards arterial smooth muscle cells owing to alternative splicing of the alpha-1 subunit of the channel and increased prevalence of inactive channels in smooth muscle cells. Isradipine may be used to treat mild to moderate essential hypertension. C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
N-[2-(3,4-Dimethoxyphenyl)ethyl]-3,4-dimethoxycinnamic acid amide
N-[2-(3,4-Dimethoxyphenyl)ethyl]-3,4-dimethoxycinnamic acid amide is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]")
N-Methyl-14-O-demethylepiporphyroxine
C20H21NO6 (371.13688060000004)
N-Methyl-14-O-demethylepiporphyroxine is an alkaloid from Papaver somniferum (opium poppy
4-(2-amino-3-hydroxyphenyl)-4-oxobutanoic acid O-glucoside
4-(2-amino-3-hydroxyphenyl)-4-oxobutanoic acid O-glucoside, also known as 4-AHPh-oba-glu, is classified as a member of the Phenolic glycosides. Phenolic glycosides are organic compounds containing a phenolic structure attached to a glycosyl moiety. Some examples of phenolic structures include lignans, and flavonoids. Among the sugar units found in natural glycosides are D-glucose, L-Fructose, and L rhamnose. 4-(2-amino-3-hydroxyphenyl)-4-oxobutanoic acid O-glucoside is considered to be slightly soluble (in water) and acidic
2-Methoxy-4-(2-(methylamino)propyl)phenyl beta-D-glucopyranosiduronic acid
2-[6-(4-Chlorophenoxy)hexyl]-1-cyano-3-pyridin-4-ylguanidine
C19H22ClN5O (371.15127920000003)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
4-Dedimethylamino sancycline
4-(1-Isopropyl-2-methyl-1H-imidazol-5-yl)-N-(4-(methylsulfonyl)phenyl)pyrimidin-2-amine
C18H21N5O2S (371.14158860000003)
Abt-751
C18H17N3O4S (371.09397220000005)
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent
Amocarzine
C18H21N5O2S (371.14158860000003)
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent
Azaribine
Baricitinib
L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants > L04AA - Selective immunosuppressants C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor COVID info from Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials, DrugBank C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C172200 - JAK Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Darodipine
C19H21N3O5 (371.14811360000004)
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Lenperone
C22H23F2NO2 (371.16967619999997)
C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent
N-(9H-Fluoren-9-ylacetyl)-L-phenylalanine
C24H21NO3 (371.15213560000007)
N-Hydroxymexiletine glucuronide
2-[4-[(2,5-Difluorophenyl)methoxy]phenoxy]-5-ethoxyaniline
C21H19F2NO3 (371.13329280000005)
(3z)-N,N-Dimethyl-2-Oxo-3-(4,5,6,7-Tetrahydro-1h-Indol-2-Ylmethylidene)-2,3-Dihydro-1h-Indole-5-Sulfonamide
C19H21N3O3S (371.13035560000003)
Hydroxydesmethylpiperine sulfate
C16H21NO7S (371.10386760000006)
1ST40203A
C20H18ClNO4 (371.09242980000005)
Berberine chloride (TN) is an organic molecular entity. Berberine Chloride is the orally bioavailable, hydrochloride salt form of berberine, a quaternary ammonium salt of an isoquinoline alkaloid and active component of various Chinese herbs, with potential antineoplastic, radiosensitizing, anti-inflammatory, anti-lipidemic and antidiabetic activities. Although the mechanisms of action through which berberine exerts its effects are not yet fully elucidated, upon administration this agent appears to suppress the activation of various proteins and/or modulate the expression of a variety of genes involved in tumorigenesis and inflammation, including, but not limited to transcription factor nuclear factor-kappa B (NF-kB), myeloid cell leukemia 1 (Mcl-1), B-cell lymphoma 2 (Bcl-2), B-cell lymphoma-extra large (Bcl-xl), cyclooxygenase (COX)-2, tumor necrosis factor (TNF), interleukin (IL)-6, IL-12, inducible nitric oxide synthase (iNOS), intercellular adhesion molecule-1 (ICAM-1), E-selectin, monocyte chemoattractant protein-1 (MCP-1), C-X-C motif chemokine 2 (CXCL2), cyclin D1, activator protein (AP-1), hypoxia-inducible factor 1 (HIF-1), signal transducer and activator of transcription 3 (STAT3), peroxisome proliferator-activated receptor (PPAR), arylamine N-acetyltransferase (NAT), and DNA topoisomerase I and II. The modulation of gene expression may induce cell cycle arrest and apoptosis, and inhibit cancer cell proliferation. In addition, berberine modulates lipid and glucose metabolism. Berberine chloride is an alkaloid that acts as an antibiotic. Berberine chloride induces reactive oxygen species (ROS) generation and inhibits DNA topoisomerase. Antineoplastic properties[1]. Berberine chloride is an alkaloid that acts as an antibiotic. Berberine chloride induces reactive oxygen species (ROS) generation and inhibits DNA topoisomerase. Antineoplastic properties[1].
1,2,9,10-tetramethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-3-ol
5-(3-nitrophenyl)-2-phenyl-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine
C22H17N3O3 (371.12698520000004)
N-(3-Cyano-1H-indol-5-yl)-3-[4-(trifluoromethoxy)phenyl]acrylamide
AZD5438
C18H21N5O2S (371.14158860000003)
N-(3-hydroxy-1,2,10-trimethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl)formamide
C20H21NO6 (371.13688060000004)
(7S)-6-methoxy-2-methyl-6,8,3,4-tetrahydro-2H-(7rN)-spiro[indeno[4,5-d][1,3]dioxole-7,1-isoquinoline]-6t,8t,7-triol|ledeboridine|Ledebouridin|ledebouridine
C20H21NO6 (371.13688060000004)
2-Demethylcolchicein|2-Desmethylcolchicein|3-Demethyl-colchicein
C20H21NO6 (371.13688060000004)
Cryptopleurospermin|Cryptopleurospermine|[6-(2-dimethylamino-ethyl)-benzo[1,3]dioxol-5-yl]-(3-hydroxy-4-methoxy-phenyl)-ethanedione
C20H21NO6 (371.13688060000004)
beta-Lumidemcolcine|beta-Lumidemecolcin|Lumidemecolcin
7-Methoxy,2,3-epoxide-8-(3,3-Dimethylallyloxy)-N-methylflindersine
5,6-dimethoxy-2-(2,5,6-trimethoxyphenyl)-1h-quinolin-4-one
C20H21NO6 (371.13688060000004)
2-Demethyl-N-deacetyl-N-formylcolchicine|2-Demethyl-N-formyl-N-desacetyl-colchicin
C20H21NO6 (371.13688060000004)
(-)-8-oxo-2,10-dihydroxy-3,9,11-trimethoxyberberine
C20H21NO6 (371.13688060000004)
7-O-(2-amino-2-deoxy-alpha-D-glucopyranosyl)-L-glycero-alpha-D-manno-heptopyranoside
C13H25NO11 (371.14275399999997)
(E)-N-[2-(4-hydroxyphenyl)-2-propoxyethyl] ferulamide
(+-)-Multifloramin|(+/-)-multifloramine|(RS)-Multifloramin|Multifloramin
(1,2,3-trimethoxy-9,10-methylenedioxynoraporphine)
N,N-dimethyl-2-oxo-3-(4,5,6,7-tetrahydro-1H-indol-2-ylmethylidene)-1H-indole-5-sulfonamide
C19H21N3O3S (371.13035560000003)
Epiberberine chloride
C20H18ClNO4 (371.09242980000005)
Epiberberine chloride is an alkaloid isolated from Coptis chinensis, acts as a potent AChE and BChE inhibitor, and a non-competitive BACE1 inhibitor, with IC50s of 1.07, 6.03 and 8.55 μM, respectively. Epiberberine chloride has antioxidant activity, with peroxynitrite ONOO- scavenging effect (IC50, 16.83 μM), and may protect against Alzheimer disease[1]. Epiberberine chloride inhibits the early stage of differentiation of 3T3-L1 preadipocytes, downregulates the Raf/MEK1/2/ERK1/2 and AMPKα/Akt pathways[2]. Epiberberine has the potential effect in the research of diabetic disease[3]. Epiberberine chloride is an alkaloid isolated from Coptis chinensis, acts as a potent AChE and BChE inhibitor, and a non-competitive BACE1 inhibitor, with IC50s of 1.07, 6.03 and 8.55 μM, respectively. Epiberberine chloride has antioxidant activity, with peroxynitrite ONOO- scavenging effect (IC50, 16.83 μM), and may protect against Alzheimer disease[1]. Epiberberine chloride inhibits the early stage of differentiation of 3T3-L1 preadipocytes, downregulates the Raf/MEK1/2/ERK1/2 and AMPKα/Akt pathways[2]. Epiberberine has the potential effect in the research of diabetic disease[3].
Demecolcine
(-)-demecolcine is a secondary amino compound that is (S)-colchicine in which the N-acetyl group is replaced by an N-methyl group. Isolable from the autumn crocus, Colchicum autumnale, it is less toxic than colchicine and is used as an antineoplastic. It has a role as an antineoplastic agent and a microtubule-destabilising agent. It is an alkaloid and a secondary amino compound. Demecolcine is a natural product found in Colchicum arenarium, Colchicum crocifolium, and other organisms with data available. Demecolcine is a colchicine analog with potential antimitotic and antineoplastic activities. Demecolcine acid binds to the colchicine-binding site of tubulin, inhibiting its polymerization into microtubules, causing cell cycle arrest at metaphase and preventing cell division. An alkaloid isolated from Colchicum autumnale L. and used as an antineoplastic. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01C - Plant alkaloids and other natural products > L01CC - Colchicine derivatives C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent D050258 - Mitosis Modulators > D050256 - Antimitotic Agents > D050257 - Tubulin Modulators D000970 - Antineoplastic Agents > D050256 - Antimitotic Agents ATC code: L01CC01 Origin: Plant; SubCategory_DNP: Isoquinoline alkaloids, Phenethylisoquinoline alkaloids, Colchicine alkaloids relative retention time with respect to 9-anthracene Carboxylic Acid is 0.681 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.679 Colcemid (Demecolcine) is a potent mitotic inhibitor with an IC50 value of 2.4 μM for inhibition of tubulin polymerization. Colcemid (Demecolcine) can interact with tubulin dimers to induce anti-mitotic action and inhibit microtubule growth. Colcemid (Demecolcine) can be used for inflammatory disorders and cancer research[1][2]. Colcemid (Demecolcine) is a potent mitotic inhibitor with an IC50 value of 2.4 μM for inhibition of tubulin polymerization. Colcemid (Demecolcine) can interact with tubulin dimers to induce anti-mitotic action and inhibit microtubule growth. Colcemid (Demecolcine) can be used for inflammatory disorders and cancer research[1][2].
Corynoxidine
Corynoxidine is a natural product found in Corydalis balansae, Corydalis speciosa, and Stephania rotunda with data available. (-)-Corynoxidine is an acetylcholinesterase inhibitor with an IC50 value of 89.0 μM, isolated from the aerial parts of Corydalis speciosa[1]. (-)-Corynoxidine exhibits antibacterial activities against Staphylococcus aureus and methicillin-resistant S. aureus strains in different degrees[2]. (-)-Corynoxidine is an acetylcholinesterase inhibitor with an IC50 value of 89.0 μM, isolated from the aerial parts of Corydalis speciosa[1]. (-)-Corynoxidine exhibits antibacterial activities against Staphylococcus aureus and methicillin-resistant S. aureus strains in different degrees[2].
Epicorynoxidine
Epicorynoxidine is a natural product found in Corydalis balansae and Stephania rotunda with data available.
C20H21NO6_6-Methoxy-2-methyl-3,4,6,8-tetrahydro-2H-spiro[indeno[4,5-d][1,3]dioxole-7,1-isoquinoline]-7,8-diol 2-oxide
C20H21NO6 (371.13688060000004)
trazodone
C19H22ClN5O (371.15127920000003)
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants D049990 - Membrane Transport Modulators Trazodone (AF-1161 free base) is a serotonin receptor antagonist and reuptake inhibitor. Trazodone can be used for the research of major depressive disorder. Trazodone also has potential for sleep disorder research[1].
Lycorine-diacetate
C20H21NO6 (371.13688060000004)
[Raw Data] CBA62_Lycorine-2Ac_pos_50eV.txt [Raw Data] CBA62_Lycorine-2Ac_pos_40eV.txt [Raw Data] CBA62_Lycorine-2Ac_pos_30eV.txt [Raw Data] CBA62_Lycorine-2Ac_pos_20eV.txt [Raw Data] CBA62_Lycorine-2Ac_pos_10eV.txt
SU 6656
C19H21N3O3S (371.13035560000003)
SU6656 is a Src family kinases inhibitor with IC50s of 280, 20, 130, 170 nM for Src, Yes, Lyn, and Fyn, respectively. SU6656 inhibits FAK phosphorylation at Y576/577, Y925, Y861 sites. SU6656 also inhibits p-AKT.
JWH 018 N-pentanoic acid metabolite
C24H21NO3 (371.15213560000007)
Alkaloid a4
C20H21NO6 (371.13688060000004)
camazepam
C19H18ClN3O3 (371.10366280000005)
N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
4-(5-hydroxy-4-oxo-2-phenylchromen-7-yl)oxybutyl nitrate
3-hydroxy-4-[4-[5-(trifluoromethyl)pyridin-2-yl]oxyphenoxy]pentanoic acid
C17H16F3NO5 (371.09805220000004)
methyl 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetate
C20H18ClNO4 (371.09242980000005)
(4-(3-CHLOROPHENYLAMINO)-1-METHYL-1H-IMIDAZO[4,5-C]PYRIDIN-7-YL)(MORPHOLINO)METHANONE
3-[[2-[4-(2-phenylethynyl)phenoxy]acetyl]amino]benzoic acid
C23H17NO4 (371.11575220000003)
1-benzamido-4-(diazonioamino)-2,5-dimethoxybenzene,tetrafluoroborate
ONO-RS-082
C21H22ClNO3 (371.1288132000001)
ONO-RS-082 is an inhibitor of phospholipase A (PLA)[1]. ONO-RS-082 inhibits PLA2 with the IC50 of 1.0 μM, but does not inhibit PLC even at 100 μM[2].
Urea, N-[(2-chloro-7,8-dimethyl-3-quinolinyl)methyl]-N-(2-furanylmethyl)-N,N-dimethyl- (9CI)
C20H22ClN3O2 (371.14004620000003)
Urea, N-[(2-chloro-6,7-dimethyl-3-quinolinyl)methyl]-N-(2-furanylmethyl)-N,N-dimethyl- (9CI)
C20H22ClN3O2 (371.14004620000003)
4-(4,6-bis(2-hydroxyethoxy)-1,3,5-triazin-2-ylamino)benzenesulfonamide
C13H17N5O6S (371.08995020000003)
N6-(2-Phenylethyl)adenosine
C18H21N5O4 (371.15934660000005)
N6-(2-Phenylethyl)adenosine (N6-Phenethyladenosine), an adenosine derivative, is a potent adenosine receptors (AR) agonist with Ki values of 11.8 nM, 30.1 nM, 0.63 nM for rat A1AR, human A1AR and hA3AR, respectively[1]. N6-(2-Phenylethyl)adenosine (N6-Phenethyladenosine), an adenosine derivative, is a potent adenosine receptors (AR) agonist with Ki values of 11.8 nM, 30.1 nM, 0.63 nM for rat A1AR, human A1AR and hA3AR, respectively[1].
(R)-N-(1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propanamide
C22H20F3NO (371.14969060000004)
Naratriptan Hydrochloride
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents Naratriptan hydrochloride is a selective 5-HT1 receptor subtype agonist and is a triptan drug that is used for the treatment of migraine headaches. Target: 5-HT1 Receptor Naratriptan is a triptan drug marketed by GlaxoSmithKline and is used for the treatment of migraine headaches. Naratriptan is available in 2.5 mg tablets. It is a selective 5-HT1 receptor subtype agonist. Naratriptan is used for the treatment of the acute migraine attacks and the symptoms of migraine, including severe, throbbing headaches that sometimes are accompanied by nausea and sensitivity to sound or light. The causes of migraine are not clearly understood; however, the efficacy of naratriptans and other triptans is believed to be due to their activity as 5HT (serotonin) agonists.A meta-analysis of 53 clinical trials has shown that all triptans are effective for treating migraine at marketed doses and that naratriptan, although less effective than sumatriptan and rizatriptan was more effective than placebo in reducing migraine symptoms at two hours and efficacy was demonstrated in almost two thirds of subjects after four hours of treatment.
N-(2,4-DIMETHYLPHENYL)-3-(PHOSPHONOOXY)-2-NAPHTHALENECARBOXAMIDE
C19H18NO5P (371.09225480000003)
4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide,dihydrochloride
6-[[2-(1-METHYLETHYL)PHENYL]]SULFONYL-5-NITRO-8-QUINOLINAMINE
C18H17N3O4S (371.09397220000005)
N-((4-NITROPHENYL)SULFONYL)-1-(TERT-BUTYLOXYCARBONYL)PIPERAZINE
1-(4,4-diphenyl-3-butenyl)-3-piperidinecarboxylicacidhydrochloride；SKF89976AHCl
C22H26ClNO2 (371.16519660000006)
SKF89976A hydrochloride is a selective GABA transporter (GAT-1) inhibitor with IC50s of 0.28 μM, 137.34 μM and 202.8 μM for GAT-1, GAT-2 and GAT-3 in CHO cells, respectively.
N-Cbz-D-glutamic acid α-benzyl ester
C20H21NO6 (371.13688060000004)
Benzyl 2-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenylcarbamate
(E)-1-(4,8-dimethoxynaphthalen-1-yl)-N-(1-prop-2-enylbenzimidazol-2-yl)methanimine
Ethyl 3-amino-2-{[(2-cyano-4-biphenylyl)methyl]amino}benzoate
Olanexidine
C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D007004 - Hypoglycemic Agents > D001645 - Biguanides
1-Benzoyl-2,3-diphenylpyrrolidine-4-carboxylic acid
C24H21NO3 (371.15213560000007)
Ethyl 8-benzyl-5-hydroxy-2-(methylthio)-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidine-6-carboxylate
C18H17N3O4S (371.09397220000005)
Methyl 4-{5-[bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2- yl}butanoate
Azaribine
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2170 - Orotidylate Decarboxylase Inhibitor D003879 - Dermatologic Agents Azaribine (2',3',5'-Tri-O-acetyl-6-azauridine) is a potent orotidine monophosphate decarboxylase (OMPD) inhibitor. Azaribine is an antiviral inhibitor of several RNA viruses and inhibits viral genome replication and gene transcription. Azaribine shows broad-spectrum antiviral activity (EC50=3.80?nM-1.73?μM against influenza A and B viruses; EC50=1.62 μM against ZIKV Paraiba). Azaribine, a triacetate salt of Azauridine, has the potential for psoriasis research[1][2].
N-(1-(NAPHTHALEN-1-YL)ETHYL)-3-(3-(TRIFLUOROMETHYL)PHENYL)PROPANAMIDE
C22H20F3NO (371.14969060000004)
7-HYDROXY-8-((2-METHOXYPHENYL)DIAZENYL)-N,N,N-TRIMETHYLNAPHTHALEN-2-AMINIUM CHLORIDE
C20H22ClN3O2 (371.14004620000003)
Xanomeline oxalate
C16H25N3O5S (371.15148400000004)
Xanomeline oxalate (LY246708 oxalate) is a potent and selective muscarinic receptor agonist (SMRA) and stimulates phosphoinositide hydrolysis in vivo. Xanomeline oxalate can be used for the research of Alzheimer’s disease[1].
(S)-4-tert-butoxycarbonyl-2-p-toluenesulfonyloxymethylmorpholine
C17H25NO6S (371.14025100000003)
N-(4-(naphthalen-1-yl)phenyl)-[1,1-biphenyl]-4-amine
3-QUINOLINECARBOXYLIC ACID, 4-CHLORO-6-METHOXY-7-(PHENYLMETHOXY)-, ETHYL ESTER
C20H18ClNO4 (371.09242980000005)
2-[(2-Acetamido-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl benzoate
tert-butyl 4-broMo-2-fluorobenzyl(cyclopentyl)carbaMate
tert-butyl 4-broMo-3-fluorobenzyl(cyclopentyl)carbaMate
N-[4-(2-Naphthalenyl)phenyl]-[1,1-biphneyl]-4-amine
N,N-diMethyl-4-((E)-4-((E)-(4-nitrobenzylidene)aMino)styryl)aniline
Benzyl 2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenylcarbamate
4-(Benzyloxycarbonylamino)-2-fluorophenylboronic acid, pinacol ester
2-Oxazolidinone,3-[(5S)-5-(4-fluorophenyl)-5-hydroxy-1-oxopentyl]-4-(phenylmethyl)-,(4S)-
C21H22FNO4 (371.15327840000003)
1-amino-4-[[4-[(dimethylamino)methyl]phenyl]amino]anthraquinone
6-methylheptoxycarbonylmethanethiolate: trimethyltin
Incyclinide
C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C1970 - Matrix Metalloproteinase Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor
1,5-Naphthyridine-3-carboxamide, 7-((4-fluorophenyl)methyl)-1,2-dihydro-4-hydroxy-N-(2-hydroxyethyl)-1-methyl-2-oxo-
C19H18FN3O4 (371.12812800000006)
SU6656
C19H21N3O3S (371.13035560000003)
SU6656 is a Src family kinases inhibitor with IC50s of 280, 20, 130, 170 nM for Src, Yes, Lyn, and Fyn, respectively. SU6656 inhibits FAK phosphorylation at Y576/577, Y925, Y861 sites. SU6656 also inhibits p-AKT.
4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic Acid
C21H13N3O4 (371.09060180000006)
[5-Amino-1-(4-fluorophenyl)-1H-pyrazol-4-YL](3-{[(2R)-2,3-dihydroxypropyl]oxy}phenyl)methanone
C19H18FN3O4 (371.12812800000006)
Ampicillin sodium
C16H18N3NaO4S (371.09156680000007)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
1-[1-oxo-2-[(4-oxo-2,3-dihydro-1H-cyclopenta[c][1]benzopyran-7-yl)oxy]ethyl]-4-piperidinecarboxylic acid
C20H21NO6 (371.13688060000004)
N-cyclohexyl-2-[[6-(4-ethoxyphenyl)-3-pyridazinyl]thio]acetamide
N-[4-[(1,2-dimethyl-5-indolyl)methylsulfamoyl]phenyl]acetamide
C19H21N3O3S (371.13035560000003)
3,5-Pyridinedicarboxylic acid, 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-, methyl 1-methylethyl ester, (4S)-
C19H21N3O5 (371.14811360000004)
(R)-N-(3-Indol-1-YL-2-methyl-propyl)-4-sulfamoyl-benzamide
C19H21N3O3S (371.13035560000003)
(S)-N-(3-Indol-1-YL-2-methyl-propyl)-4-sulfamoyl-benzamide
C19H21N3O3S (371.13035560000003)
N-[2-(1H-Indol-5-YL)-butyl]-4-sulfamoyl-benzamide
C19H21N3O3S (371.13035560000003)
Baricitinib
L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants > L04AA - Selective immunosuppressants C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor COVID info from Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials, DrugBank C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C172200 - JAK Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Lenperone
C22H23F2NO2 (371.16967619999997)
C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent
Darodipine
C19H21N3O5 (371.14811360000004)
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
(2S)-2-[[2-[(1R,2S)-3-oxo-2-[(Z)-5-oxopent-2-enyl]cyclopentyl]acetyl]amino]-3-phenylpropanoic acid
2-[1-[2-Oxo-2-[(4-thiophen-2-ylphenyl)methylamino]ethyl]cyclohexyl]acetic acid
C21H25NO3S (371.15550600000006)
(S)-averantin(1-)
A phenolate anion obtained by deprotonation of the 2-hydroxy group of (S)-averantin. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).
(+)-N-(methoxycarbonyl)-N-norboldine
C20H21NO6 (371.13688060000004)
An aporphine alkaloid that is laurolistine with a N-methoxycarbonyl group. Isolated from the aerial parts of Litsea cubeba, it exhibits antimicrobial activities.
4-hydroxy-1-(3-methylbutyl)-N-(5-methyl-1,3-thiazol-2-yl)-2-oxo-1,2-dihydroquinoline-3-carboxamide
C19H21N3O3S (371.13035560000003)
1-[2-(2-Amino-3-cyano-1-pyrrolo[3,2-b]quinoxalinyl)ethyl]-3-phenylurea
5-[[2,3-Dihydro-1,4-benzodioxin-3-yl(oxo)methyl]amino]benzene-1,3-dicarboxylic acid dimethyl ester
(5Z)-3-hexyl-5-[(5-phenyl-1H-pyrazol-4-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one
4-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(3,4-dimethoxyphenyl)-1H-1,2,4-triazole-5-thione
C18H17N3O4S (371.09397220000005)
1-[[1-Oxo-3-(4-propan-2-yloxyphenyl)propyl]amino]-3-(phenylmethyl)thiourea
3-{[5-(4-hydroxyphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl}-N-(2-methoxyphenyl)propanamide
C18H17N3O4S (371.09397220000005)
5-(2,3-Dihydroindol-1-ylsulfonyl)-1,3-diethyl-2-benzimidazolone
C19H21N3O3S (371.13035560000003)
[4-[[4-(Methylthio)phenyl]methyl]-1-piperazinyl]-(4-nitrophenyl)methanone
C19H21N3O3S (371.13035560000003)
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[(6-methoxy-1H-benzimidazol-2-yl)thio]acetamide
C18H17N3O4S (371.09397220000005)
3-Methyl-1-phenyl-5-thieno[2,3-c]pyrazolecarboxylic acid [2-(butylamino)-2-oxoethyl] ester
C19H21N3O3S (371.13035560000003)
N-(1,3-benzothiazol-2-yl)-2-[(E)-(3,4-dimethoxyphenyl)methylideneamino]oxyacetamide
C18H17N3O4S (371.09397220000005)
2-[4-[(4-chlorophenyl)methyl]piperazin-1-yl]-N-[(E)-pyridin-4-ylmethylideneamino]acetamide
C19H22ClN5O (371.15127920000003)
2-[3-(4-Methoxyphenyl)-1-benzo[f]quinolinyl]acetic acid ethyl ester
C24H21NO3 (371.15213560000007)
2-(2,5-Difluorophenyl)-5-methyl-4-[[4-(2-pyrazinyl)-1-piperazinyl]methyl]oxazole
4-methyl-N-(3-methylbutyl)-5-(5-methyl-3-phenyl-4H-isoxazol-5-yl)-2-thiazolecarboxamide
1-[4-(3-Hydroxy-2-methoxyphenyl)-4-(3-hydroxy-4-methoxyphenyl)-1-piperidinyl]ethanone
N-[(8-methoxy-5-nitro-7-quinolinyl)-thiophen-2-ylmethyl]propanamide
C18H17N3O4S (371.09397220000005)
4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-3,4-dihydropyridine-3,5-dicarboxylic acid O3-methyl ester O5-propan-2-yl ester
C19H21N3O5 (371.14811360000004)
(4aS,5aR,12aS)-10,12a-dihydroxy-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide
5-(dimethylamino)-N-[4-(hydroxyamino)benzyl]naphthalene-1-sulfonamide
C19H21N3O3S (371.13035560000003)
1-(2-chlorophenyl)-N-[(1-cyclopentyl-5-tetrazolyl)methyl]-N-(2-furanylmethyl)methanamine
C19H22ClN5O (371.15127920000003)
2-[(2S,3R,6R)-2-(hydroxymethyl)-3-[(4-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester
C16H21NO7S (371.10386760000006)
methyl 2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]acetate
C16H21NO7S (371.10386760000006)
(2R,3S,4R)-3-[4-(2-cyclopropylethynyl)phenyl]-4-(hydroxymethyl)-1-[1-oxo-2-(2-pyridinyl)ethyl]-2-azetidinecarbonitrile
methyl 2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]acetate
C16H21NO7S (371.10386760000006)
methyl 2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]acetate
C16H21NO7S (371.10386760000006)
(2R,3R,4S)-3-[4-(2-cyclopropylethynyl)phenyl]-4-(hydroxymethyl)-1-[1-oxo-2-(2-pyridinyl)ethyl]-2-azetidinecarbonitrile
(2S,3R,4S)-3-[4-(2-cyclopropylethynyl)phenyl]-4-(hydroxymethyl)-1-[1-oxo-2-(2-pyridinyl)ethyl]-2-azetidinecarbonitrile
(2S,3R,4R)-3-[4-(2-cyclopropylethynyl)phenyl]-4-(hydroxymethyl)-1-(2-pyridin-2-ylacetyl)azetidine-2-carbonitrile
2-[(2S,5R,6S)-5-(ethylsulfonylamino)-6-(hydroxymethyl)-2-oxanyl]-N-(2-pyridinylmethyl)acetamide
C16H25N3O5S (371.15148400000004)
2-[(2R,3S,6R)-2-(hydroxymethyl)-3-[(4-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester
C16H21NO7S (371.10386760000006)
2-[(2R,3R,6S)-2-(hydroxymethyl)-3-[(4-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester
C16H21NO7S (371.10386760000006)
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid methyl ester
C16H21NO7S (371.10386760000006)
(2S,3S,3aR,9bR)-7-(4-fluorophenyl)-3-(hydroxymethyl)-N,N-dimethyl-6-oxo-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizine-2-carboxamide
C20H22FN3O3 (371.16451140000004)
2-[(2S,5S,6R)-5-(ethylsulfonylamino)-6-(hydroxymethyl)-2-oxanyl]-N-(2-pyridinylmethyl)acetamide
C16H25N3O5S (371.15148400000004)
2-[(2R,3S,6S)-2-(hydroxymethyl)-3-[(4-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester
C16H21NO7S (371.10386760000006)
2-[(2S,3R,6S)-2-(hydroxymethyl)-3-[(4-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester
C16H21NO7S (371.10386760000006)
2-[(2S,3S,6R)-2-(hydroxymethyl)-3-[(4-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester
C16H21NO7S (371.10386760000006)
2-[(2S,3S,6S)-2-(hydroxymethyl)-3-[(4-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester
C16H21NO7S (371.10386760000006)
2-[(2R,3R,6R)-2-(hydroxymethyl)-3-[(4-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetic acid methyl ester
C16H21NO7S (371.10386760000006)
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid methyl ester
C16H21NO7S (371.10386760000006)
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid methyl ester
C16H21NO7S (371.10386760000006)
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid methyl ester
C16H21NO7S (371.10386760000006)
(2R,3R,3aS,9bS)-7-(4-fluorophenyl)-3-(hydroxymethyl)-N,N-dimethyl-6-oxo-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizine-2-carboxamide
C20H22FN3O3 (371.16451140000004)
hydron;N-methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide;chloride
(2E)-2-[(E)-benzylidenehydrazinylidene]-5,5-diphenyl-1,3-thiazolidin-4-one
(4S)-2-(1,3-benzothiazol-2-yl)-5-methyl-4-(naphthalen-1-ylmethyl)-4H-pyrazol-3-one
2-Amino-3-[2,3-di(propanoyloxy)propoxy-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[(3-heptanoyloxy-2-hydroxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
C13H26NO9P (371.13451160000005)
(11S,12S,13S)-16,17-dimethoxy-11-methyl-11-oxido-3,5-dioxa-11-azoniapentacyclo[10.7.1.02,6.08,20.014,19]icosa-1(20),2(6),7,14,16,18-hexaen-13-ol
C20H21NO6 (371.13688060000004)
3-[(3-Acetyloxy-2-butanoyloxypropoxy)-hydroxyphosphoryl]oxy-2-aminopropanoic acid
(11R,12S,13S)-16,17-dimethoxy-11-methyl-11-oxido-3,5-dioxa-11-azoniapentacyclo[10.7.1.02,6.08,20.014,19]icosa-1(20),2(6),7,14,16,18-hexaen-13-ol
C20H21NO6 (371.13688060000004)
Berberinum
C20H18NO4. Cl (371.09242980000005)
Berberine chloride (TN) is an organic molecular entity. Berberine Chloride is the orally bioavailable, hydrochloride salt form of berberine, a quaternary ammonium salt of an isoquinoline alkaloid and active component of various Chinese herbs, with potential antineoplastic, radiosensitizing, anti-inflammatory, anti-lipidemic and antidiabetic activities. Although the mechanisms of action through which berberine exerts its effects are not yet fully elucidated, upon administration this agent appears to suppress the activation of various proteins and/or modulate the expression of a variety of genes involved in tumorigenesis and inflammation, including, but not limited to transcription factor nuclear factor-kappa B (NF-kB), myeloid cell leukemia 1 (Mcl-1), B-cell lymphoma 2 (Bcl-2), B-cell lymphoma-extra large (Bcl-xl), cyclooxygenase (COX)-2, tumor necrosis factor (TNF), interleukin (IL)-6, IL-12, inducible nitric oxide synthase (iNOS), intercellular adhesion molecule-1 (ICAM-1), E-selectin, monocyte chemoattractant protein-1 (MCP-1), C-X-C motif chemokine 2 (CXCL2), cyclin D1, activator protein (AP-1), hypoxia-inducible factor 1 (HIF-1), signal transducer and activator of transcription 3 (STAT3), peroxisome proliferator-activated receptor (PPAR), arylamine N-acetyltransferase (NAT), and DNA topoisomerase I and II. The modulation of gene expression may induce cell cycle arrest and apoptosis, and inhibit cancer cell proliferation. In addition, berberine modulates lipid and glucose metabolism. Berberine chloride is an alkaloid that acts as an antibiotic. Berberine chloride induces reactive oxygen species (ROS) generation and inhibits DNA topoisomerase. Antineoplastic properties[1]. Berberine chloride is an alkaloid that acts as an antibiotic. Berberine chloride induces reactive oxygen species (ROS) generation and inhibits DNA topoisomerase. Antineoplastic properties[1].
NEDOCROMIL
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BC - Antiallergic agents, excl. corticosteroids R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AC - Antiallergic agents, excl. corticosteroids S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D000893 - Anti-Inflammatory Agents > D000082142 - Mast Cell Stabilizers D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents D018926 - Anti-Allergic Agents D007155 - Immunologic Factors Nedocromil suppresses the action or formation of multiple mediators, including histamine, leukotriene C4 (LTC4), and prostaglandin D2 (PGD2).
Abt-751
C18H17N3O4S (371.09397220000005)
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent
GMX1778
C19H22ClN5O (371.15127920000003)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
ent-glycosmisate
A monocarboxylic acid anion that is the conjugate base of ent-glycosmisic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.
Amocarzine
C18H21N5O2S (371.14158860000003)
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent
N-Methyl-14-O-demethylepiporphyroxine
C20H21NO6 (371.13688060000004)
4-(2-amino-3-hydroxyphenyl)-4-oxobutanoic acid O-glucoside
N,N-dimethyl-2-oxo-3-(4,5,6,7-tetrahydro-1H-indol-2-ylmethylene)indoline-5-sulfonamide
C19H21N3O3S (371.13035560000003)
glycosmisate
A monocarboxylic acid anion that is the conjugate base of glycosmisic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.
(-)-Demecolcine
A secondary amino compound that is (S)-colchicine in which the N-acetyl group is replaced by an N-methyl group. Isolable from the autumn crocus, Colchicum autumnale, it is less toxic than colchicine and is used as an antineoplastic.
FITM
C18H18FN5OS (371.12160300000005)
FITM is a negative allosteric modulator of mGlu1 receptor with a Ki of 2.5 nM.
VUF-5574
VUF-5574 is a selective antagonist of adenosine A3 receptor with a Ki of 4.03 nM for the recombinant human receptor[1].
Z16078526
C18H17N3O4S (371.09397220000005)
Z16078526 induces endogenous Ucp1 expression, promotes p38 MAPK phosphorylation and lipolysis in primary mouse brown adipocytes. Z16078526 activates thermogenic gene expression and mitochondrial activity (uncoupled respiration) in mouse brown adipocytes. Z16078526 also stimulates thermogenesis in the mouse[1].
(1r)-11,17-dimethoxy-6,8,12-trioxa-22-azapentacyclo[11.9.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁹]docosa-2(10),3,5(9),14(19),15,17-hexaen-16-ol
C20H21NO6 (371.13688060000004)
n-{5-hydroxy-3,4,14-trimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2,4,6,11,14-hexaen-10-yl}carboximidic acid
C20H21NO6 (371.13688060000004)
(1s)-5,6,7-trimethoxy-1-[(6-methyl-2h-1,3-benzodioxol-5-yl)methyl]-1,2,3,4-tetrahydroisoquinoline
13-hydroxy-15,16-dimethoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-11-ium-11-olate
C20H21NO6 (371.13688060000004)
(6r,12br)-2,3,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-6-ium-6-olate
n-[(10s)-4-hydroxy-3,5,14-trimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl]carboximidic acid
C20H21NO6 (371.13688060000004)
14-acetyl-5-hydroxy-9-methyl-4,10-dioxa-14-azapentacyclo[11.7.0.0¹,⁵.0⁷,¹².0¹⁵,²⁰]icosa-15,17,19-triene-8-carbaldehyde
n-[(10s,12r,16s)-5-hydroxy-3,4,14-trimethoxy-13-oxotetracyclo[9.5.0.0²,⁷.0¹²,¹⁶]hexadeca-1(11),2,4,6,14-pentaen-10-yl]carboximidic acid
C20H21NO6 (371.13688060000004)
(2s)-4,9-dihydroxy-2-(2-hydroxypropan-2-yl)-11-methoxy-10-methyl-2h,3h-furo[3,2-b]acridin-5-one
C20H21NO6 (371.13688060000004)
4,16,17-trimethoxy-11-methyl-11-azatetracyclo[8.7.1.0²,⁷.0¹⁴,¹⁸]octadeca-1(17),2(7),3,5,14(18),15-hexaene-3,5-diol
(2s)-n-{6-[(r)-(acetyloxy)(phenyl)methyl]-4-oxopyran-3-carbonyl}-2-methylbutanimidic acid
C20H21NO6 (371.13688060000004)
5,6,7-trimethoxy-1-[(6-methyl-2h-1,3-benzodioxol-5-yl)methyl]-1,2,3,4-tetrahydroisoquinoline
(12br)-2,3,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-6-ium-6-olate
5-hydroxy-2-[hydroxy(4-hydroxyphenyl)methyl]-4-(1-hydroxy-4,6-dimethylocta-2,4-dien-1-ylidene)-2h-pyrrol-3-one
(2e)-4-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-2-methylbut-2-en-1-yl acetate
C20H21NO6 (371.13688060000004)
(5s,9bs,11r)-7,8,11-trimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-5-yl acetate
10-(dimethylamino)-5-hydroxy-3,4,14-trimethoxytricyclo[9.5.0.0²,⁷]hexadeca-1(16),2,4,6,11,14-hexaen-13-one
3,4,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-2-ol
6-methoxy-3-{7-methoxy-9h-pyrido[3,4-b]indole-1-carbonyl}-1h-indole
C22H17N3O3 (371.12698520000004)
(10r)-3,4,5,14-tetramethoxy-10-(methylamino)tricyclo[9.5.0.0²,⁷]hexadeca-1(16),2,4,6,11,14-hexaen-13-one
(9s)-4,5,14,15,16-pentamethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaene
16-oxodelavaine
C20H21NO6 (371.13688060000004)
{"Ingredient_id": "HBIN001942","Ingredient_name": "16-oxodelavaine","Alias": "NA","Ingredient_formula": "C20H21NO6","Ingredient_Smile": "CN1C2CC3=CC4=C(C=C3C5(C2C(=C(C(=O)C5)OC)OC)CC1=O)OCO4","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "16299","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
acutifolidine; (s)-form
{"Ingredient_id": "HBIN014655","Ingredient_name": "acutifolidine; (s)-form","Alias": "NA","Ingredient_formula": "C21H25NO5","Ingredient_Smile": "NA","Ingredient_weight": "371.43","OB_score": "NA","CAS_id": "126595-93-5","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7166","PubChem_id": "NA","DrugBank_id": "NA"}
(2e,4e,6r)-1-[(5s)-2,4-dihydroxy-5-[(r)-hydroxy(4-hydroxyphenyl)methyl]-5h-pyrrol-3-yl]-4,6-dimethylocta-2,4-dien-1-one
(2s)-1-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-3-methylbut-3-en-2-yl acetate
C20H21NO6 (371.13688060000004)
3,5,17-trimethoxy-11-methyl-11-azatetracyclo[8.7.1.0²,⁷.0¹⁴,¹⁸]octadeca-1(17),2(7),3,5,14(18),15-hexaene-4,16-diol
methyl 7-[2-(dimethylamino)ethyl]-10-hydroxy-9-methoxy-1-oxobenzo[h]isochromene-3-carboxylate
C20H21NO6 (371.13688060000004)
(10s)-3,5,17-trimethoxy-11-methyl-11-azatetracyclo[8.7.1.0²,⁷.0¹⁴,¹⁸]octadeca-1(17),2(7),3,5,14(18),15-hexaene-4,16-diol
3-(3,4-dimethoxyphenyl)-n-[2-(3,4-dimethoxyphenyl)ethyl]prop-2-enimidic acid
(2s,3s,4s,5s,6r)-6-[(1s)-2-{[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1-hydroxyethyl]oxane-2,3,4,5-tetrol
C13H25NO11 (371.14275399999997)
(7s,8r)-7',8-dihydroxy-6'-methoxy-2'-methyl-3',4',6,8-tetrahydro-2h-spiro[indeno[4,5-d][1,3]dioxole-7,1'-isoquinolin]-2'-ium-2'-olate
C20H21NO6 (371.13688060000004)
n-[(10s)-4,14-dihydroxy-3,5-dimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl]ethanimidic acid
C20H21NO6 (371.13688060000004)
(9s)-4,5,15,16-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-14-ol
4,5,16-trimethoxy-11-methyl-11-azatetracyclo[8.7.1.0²,⁷.0¹⁴,¹⁸]octadeca-1(17),2(7),3,5,14(18),15-hexaene-3,17-diol
(12s)-7,16,17-trimethoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14(19),15,17-hexaen-15-ol
C20H21NO6 (371.13688060000004)
17-(acetyloxy)-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]nonadeca-2,4(8),9,15-tetraen-18-yl acetate
C20H21NO6 (371.13688060000004)
3,5,8-trihydroxy-6-methoxy-2,2,7-trimethyl-3,4-dihydro-1-oxa-7-azatetraphen-12-one
C20H21NO6 (371.13688060000004)
(12s,13s)-13-hydroxy-15,16-dimethoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-11-ium-11-olate
C20H21NO6 (371.13688060000004)
(6r,12bs)-3,4,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-6-ium-6-olate
6-[(5s)-2h,5h,6h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-ylmethyl]-2,3-dimethoxybenzoic acid
C20H21NO6 (371.13688060000004)
(12bs)-3,4,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-2-ol
methyl 3-(5-hydroxy-1h-indol-3-yl)-4-(1h-indol-3-yl)-1h-pyrrole-2-carboxylate
C22H17N3O3 (371.12698520000004)
n-{5,14-dihydroxy-3,4-dimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2,4,6,11,14-hexaen-10-yl}ethanimidic acid
C20H21NO6 (371.13688060000004)
10-(2-hydroxypropyl)-4,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaene-3,15-diol
(12bs)-3,4,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-6-ium-6-olate
n-[2-(4-methoxyphenyl)ethyl]-3-(3,4,5-trimethoxyphenyl)prop-2-enimidic acid
n-[(10r)-5-hydroxy-3,4,14-trimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2,4,6,11,14-hexaen-10-yl]carboximidic acid
C20H21NO6 (371.13688060000004)
(6s,12br)-3,4,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-6-ium-6-olate
6-(2-{[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1-hydroxyethyl)oxane-2,3,4,5-tetrol
C13H25NO11 (371.14275399999997)
11,17-dimethoxy-6,8,12-trioxa-22-azapentacyclo[11.9.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁹]docosa-2(10),3,5(9),14(19),15,17-hexaen-16-ol
C20H21NO6 (371.13688060000004)
(10s)-3,4,16-trimethoxy-11-methyl-11-azatetracyclo[8.7.1.0²,⁷.0¹⁴,¹⁸]octadeca-1(17),2(7),3,5,14(18),15-hexaene-5,17-diol
(6s,12br)-2,3,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-6-ium-6-olate
(2s)-4-[(2e,4e,6s,7s)-1,7-dihydroxy-4,6-dimethylocta-2,4-dien-1-ylidene]-5-hydroxy-2-[(4-hydroxyphenyl)methyl]-2h-pyrrol-3-one
(1s,17s,18s,19s)-17-(acetyloxy)-5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]nonadeca-2,4(8),9,15-tetraen-18-yl acetate
C20H21NO6 (371.13688060000004)
4,14,15,16-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-5-ol
6-[(7-hydroxy-2-methyl-6-oxo-3,4-dihydroisoquinolin-1-yl)methyl]-2,3-dimethoxybenzoic acid
C20H21NO6 (371.13688060000004)
2,3,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-12-ol
n-{4-hydroxy-3,5,14-trimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl}carboximidic acid
C20H21NO6 (371.13688060000004)
4,5,14,16-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-15-ol
n-[(10s)-4,5-dihydroxy-3,14-dimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl]ethanimidic acid
C20H21NO6 (371.13688060000004)
4-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-2-methylbut-2-en-1-yl acetate
C20H21NO6 (371.13688060000004)
4,9-dihydroxy-2-(2-hydroxypropan-2-yl)-11-methoxy-10-methyl-2h,3h-furo[3,2-b]acridin-5-one
C20H21NO6 (371.13688060000004)
3,4,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-9-ol
n-{4,5-dihydroxy-3,14-dimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl}ethanimidic acid
C20H21NO6 (371.13688060000004)
n-{4,14-dihydroxy-3,5-dimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl}ethanimidic acid
C20H21NO6 (371.13688060000004)
(1s,5s,7r,8s,9r,12r,13s)-14-acetyl-5-hydroxy-9-methyl-4,10-dioxa-14-azapentacyclo[11.7.0.0¹,⁵.0⁷,¹².0¹⁵,²⁰]icosa-15,17,19-triene-8-carbaldehyde
(10s)-3,4,17-trimethoxy-11-methyl-11-azatetracyclo[8.7.1.0²,⁷.0¹⁴,¹⁸]octadeca-1(17),2,4,6,14(18),15-hexaene-5,16-diol
(9r)-4,5,14,16-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-15-ol
3,11-dihydroxy-2,4,10-trimethoxy-7,8,12b,13-tetrahydro-6-azatetraphen-5-one
C20H21NO6 (371.13688060000004)
(6s,12bs)-3,4,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-6-ium-6-olate
3-[(2s)-butan-2-yl]-4-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}-2,5-dioxopyrrol-1-yl acetate
1-{6-[2-(dimethylamino)ethyl]-2h-1,3-benzodioxol-5-yl}-2-(3-hydroxy-4-methoxyphenyl)ethane-1,2-dione
C20H21NO6 (371.13688060000004)
(10s)-3,5,16-trimethoxy-11-methyl-11-azatetracyclo[8.7.1.0²,⁷.0¹⁴,¹⁸]octadeca-1(17),2(7),3,5,14(18),15-hexaene-4,17-diol
(12bs)-3,4,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-9-ol
(2e)-n-[2-(4-methoxyphenyl)ethyl]-3-(3,4,5-trimethoxyphenyl)prop-2-enimidic acid
n-[(10r)-5,14-dihydroxy-3,4-dimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2,4,6,11,14-hexaen-10-yl]ethanimidic acid
C20H21NO6 (371.13688060000004)
(2e)-3-(4-hydroxy-3-methoxyphenyl)-n-[(2s)-2-(4-hydroxyphenyl)-2-propoxyethyl]prop-2-enimidic acid
10-hydroxy-5,7-dimethyl-12-methylidene-16-oxa-7-azahexacyclo[9.7.2.0¹,⁸.0⁵,¹⁸.0⁹,¹⁴.0¹⁴,¹⁹]icosane-3,15,17-trione
3,4,16-trimethoxy-11-methyl-11-azatetracyclo[8.7.1.0²,⁷.0¹⁴,¹⁸]octadeca-1(17),2(7),3,5,14(18),15-hexaene-5,17-diol
(1s,5r,8s,9s,10s,11s,14r,18r,19s)-10-hydroxy-5,7-dimethyl-12-methylidene-16-oxa-7-azahexacyclo[9.7.2.0¹,⁸.0⁵,¹⁸.0⁹,¹⁴.0¹⁴,¹⁹]icosane-3,15,17-trione
(9s)-4,5,14,15-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-16-ol
(10r)-3,4,16-trimethoxy-11-methyl-11-azatetracyclo[8.7.1.0²,⁷.0¹⁴,¹⁸]octadeca-1(17),2(7),3,5,14(18),15-hexaene-5,17-diol
(10s)-10-(dimethylamino)-5-hydroxy-3,4,14-trimethoxytricyclo[9.5.0.0²,⁷]hexadeca-1(16),2,4,6,11,14-hexaen-13-one
6-[(5r)-2h,5h,6h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-ylmethyl]-2,3-dimethoxybenzoic acid
C20H21NO6 (371.13688060000004)
4,14,15,16-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-3-ol
(10s)-4,5,16-trimethoxy-11-methyl-11-azatetracyclo[8.7.1.0²,⁷.0¹⁴,¹⁸]octadeca-1(17),2(7),3,5,14(18),15-hexaene-3,17-diol
(2s)-5-hydroxy-2-[(s)-hydroxy(4-hydroxyphenyl)methyl]-4-[(2e,4e,6r)-1-hydroxy-4,6-dimethylocta-2,4-dien-1-ylidene]-2h-pyrrol-3-one
(1r,11r,13s)-11,17-dimethoxy-6,8,12-trioxa-22-azapentacyclo[11.9.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁹]docosa-2(10),3,5(9),14(19),15,17-hexaen-16-ol
C20H21NO6 (371.13688060000004)
(3r)-3-hydroxy-3-methyl-4-(1,4,5-trihydroxy-9,10-dioxoanthracen-2-yl)butanimidic acid
(11s,12s,13s)-13-hydroxy-15,16-dimethoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-11-ium-11-olate
C20H21NO6 (371.13688060000004)
7,8,11-trimethoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-5-yl acetate
(9r)-4,5,14,15-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-16-ol
(1s,11s,13s)-11,17-dimethoxy-6,8,12-trioxa-22-azapentacyclo[11.9.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁹]docosa-2(10),3,5(9),14(19),15,17-hexaen-16-ol
C20H21NO6 (371.13688060000004)
n-{6-[(r)-(acetyloxy)(phenyl)methyl]-4-oxopyran-3-carbonyl}-3-methylbutanimidic acid
C20H21NO6 (371.13688060000004)
(9r)-4,5,14,15,16-pentamethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaene
(12bs)-3,11-dihydroxy-2,4,10-trimethoxy-7,8,12b,13-tetrahydro-6-azatetraphen-5-one
C20H21NO6 (371.13688060000004)
3-(4-hydroxy-3-methoxyphenyl)-n-[2-(4-hydroxyphenyl)-2-propoxyethyl]prop-2-enimidic acid
n-[(10s)-5-hydroxy-3,4,14-trimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2,4,6,11,14-hexaen-10-yl]carboximidic acid
C20H21NO6 (371.13688060000004)
5,6-dimethoxy-2-(2,3,6-trimethoxyphenyl)-1h-quinolin-4-one
C20H21NO6 (371.13688060000004)
(2e)-3-(3,4-dimethoxyphenyl)-n-[2-(3,4-dimethoxyphenyl)ethyl]prop-2-enimidic acid
(10s,12r,16s)-3,4,5,14-tetramethoxy-10-(methylamino)tetracyclo[9.5.0.0²,⁷.0¹²,¹⁶]hexadeca-1(11),2,4,6,14-pentaen-13-one
(12br)-3,4,10,11-tetramethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-12-ol
(9s)-4,14,15,16-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-3-ol
1-{[(2z)-4-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)but-2-en-2-yl]oxy}propan-2-one
C20H21NO6 (371.13688060000004)
methyl 3,4,8-trimethoxy-10-nitrophenanthrene-1-carboxylate
(6r,7s,8s)-6'-methoxy-2'-methyl-3',4',6,8-tetrahydro-2h-spiro[indeno[4,5-d][1,3]dioxole-7,1'-isoquinoline]-6,7',8-triol
C20H21NO6 (371.13688060000004)
14,15-dimethoxy-20-methyl-5,7-dioxa-20-azapentacyclo[11.4.3.0¹,¹³.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,14-tetraene-16,19-dione
C20H21NO6 (371.13688060000004)
methyl 2-[(3z)-6-[2-(dimethylamino)ethyl]-9-hydroxy-8-methoxy-1-oxonaphtho[1,2-c]furan-3-ylidene]acetate
C20H21NO6 (371.13688060000004)
(1s,13r)-14,15-dimethoxy-20-methyl-5,7-dioxa-20-azapentacyclo[11.4.3.0¹,¹³.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,14-tetraene-16,19-dione
C20H21NO6 (371.13688060000004)
n-{5-hydroxy-3,4,14-trimethoxy-13-oxotetracyclo[9.5.0.0²,⁷.0¹²,¹⁶]hexadeca-1(11),2,4,6,14-pentaen-10-yl}carboximidic acid
C20H21NO6 (371.13688060000004)
5,6-dimethoxy-2-(2,3,5-trimethoxyphenyl)-1h-quinolin-4-one
C20H21NO6 (371.13688060000004)
6'-methoxy-2'-methyl-3',4',6,8-tetrahydro-2h-spiro[indeno[4,5-d][1,3]dioxole-7,1'-isoquinoline]-6,7',8-triol
C20H21NO6 (371.13688060000004)
n-{6-[(acetyloxy)(phenyl)methyl]-4-oxopyran-3-carbonyl}-3-methylbutanimidic acid
C20H21NO6 (371.13688060000004)